Manipulation of the Quorum Sensing Signal AI-2 Affects the Antibiotic-Treated Gut Microbiota  by Thompson, Jessica Ann et al.
ArticleManipulation of the Quorum Sensing Signal AI-2
Affects the Antibiotic-Treated Gut MicrobiotaGraphical AbstractHighlightsd Streptomycin almost clears Firmicutes as Bacteroidetes
dominate the gut microbiota
d Engineered Escherichia coli manipulate AI-2 levels in the
mouse gut
d AI-2 produced by E. coli favors the Firmicutes while hindering
the Bacteroidetes
d AI-2 can shape the microbiota composition under conditions
of dysbiosisThompson et al., 2015, Cell Reports 10, 1861–1871
March 24, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.02.049Authors
Jessica Ann Thompson,
Rita Almeida Oliveira, ..., Carles Ubeda,
Karina Bivar Xavier
Correspondence
kxavier@igc.gulbenkian.pt
In Brief
The balance between the Bacteroidetes
and Firmicutes phyla in the gut bacterial
community influences host health.
Thompson et al. investigate the impact of
the interspecies signal autoinducer-2 on
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the Bacteroidetes, increased AI-2
counteracts antibiotic-induced dysbiosis
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The mammalian gut microbiota harbors a diverse
ecosystem where hundreds of bacterial species
interactwitheachother and their host.Given that bac-
teria use signals to communicate and regulate group
behaviors (quorum sensing), we asked whether such
communication between different commensal spe-
cies can influence the interactions occurring in this
environment. We engineered the enteric bacterium,
Escherichia coli, to manipulate the levels of the inter-
species quorum sensing signal, autoinducer-2 (AI-2),
in the mouse intestine and investigated the effect
upon antibiotic-induced gut microbiota dysbiosis.
E. coli that increased intestinal AI-2 levels altered
the composition of the antibiotic-treated gut micro-
biota, favoring the expansion of the Firmicutes
phylum. This significantly increased the Firmicutes/
Bacteroidetes ratio, to oppose the strong effect of
the antibiotic, which had almost cleared the Firmi-
cutes. This demonstrates that AI-2 levels influence
the abundance of the major phyla of the gut micro-
biota, the balance of which is known to influence
human health.
INTRODUCTION
The mammalian intestinal tract is home to approximately 1014
bacteria, encoding over 100-fold more genes than are within
the human genome (Savage, 1977). This complement to the
host’s coding capacity provides a repertoire of additional
metabolic functions including the digestion of complex polysac-
charides, production of fatty acids, and vitamin biosynthesis
(Arumugam et al., 2011; Louis et al., 2014). Interactions between
commensal species and the host fulfill immensely important
physiological roles, promoting the development of the intestinal
tract, maturation of the immune system, and immunological
tolerance to antigens (Berg, 1996; Hooper et al., 2012; Rakoff-
Nahoum et al., 2004). These bacteria also provide a major pro-
tective barrier against pathogens, through a phenomenon knownCellas colonization resistance (Bohnhoff and Miller, 1962; Lawley
and Walker, 2013).
Though the gut microbiota is clearly beneficial in many ways,
imbalances in this community (dysbiosis), including those
induced by diet or antimicrobial usage, can pose a threat to
host health. Antibiotics such as clindamycin or ampicillin that
alter the commensal bacterial community also increase host
susceptibility to opportunists such as Clostridium difficile and
vancomycin-resistant enterococci (Buffie et al., 2012; Ubeda
et al., 2010). Furthermore, shifts in the composition of the micro-
biota, particularly those involving the two predominant phyla in
the mammalian gut, the Bacteroidetes and the Firmicutes, are
associated with the pathogenesis of obesity, diabetes, chronic
inflammatory bowel diseases, and gastrointestinal cancer, as
well as autism and stress (Finegold et al., 2010; Frank et al.,
2007; Galley et al., 2014; Ley et al., 2006; Qin et al., 2012; Turn-
baugh et al., 2006; Wang et al., 2012). Consequently, the ability
to drive this community from disease-associated to healthy
states, by manipulating the native signals and interactions that
occur between its members, to restore colonization resistance,
for example, offers great potential for therapeutic benefit.
The mechanisms through which the resident microbial com-
munity inhibits the growth of invading microbes remain largely
unknown, but there is increasing evidence that direct microbe-
microbe interactions play a critical role in this process (Buffie
et al., 2015; Hsiao et al., 2014; Kamada et al., 2012, 2013; Ng
et al., 2013; Reeves et al., 2012). Cross-feeding and metabolic
interactions clearly influence the composition of the microbiota
(Buffie et al., 2015; Fabich et al., 2008; Flint et al., 2007; Kamada
et al., 2012; Leatham et al., 2009; Ng et al., 2013). Bacteria also
harbor vast arrays of mechanisms to sense and respond to
features of their environment, including the presence of other
bacteria. Small diffusible molecules known as autoinducers are
synthesized and released in accordance with cell number; their
subsequent detection enables bacteria to synchronously regu-
late behaviors at the population level in a process known as
quorum sensing (Rutherford and Bassler, 2012). Attachment,
biofilm formation, motility, and virulence are among the many
phenotypes controlled in this manner. As quorum sensing
and the behaviors it regulates are important in many bacteria-
bacteria interactions in the host context, both symbiotic and
pathogenic (Ruby, 2008; Rutherford and Bassler, 2012), thisReports 10, 1861–1871, March 24, 2015 ª2015 The Authors 1861
phenomenon is likely to also contribute to the interactions be-
tween bacteria inhabiting the mammalian gut.
Many quorum sensing signals are species specific; however,
production of and responses to one molecule, autoinducer-2
(AI-2), are observed throughout the bacterial kingdom (Chen
et al., 2002; Miller et al., 2004; Pereira et al., 2013). As AI-2 pro-
duced by one species can influence gene expression in another,
this signal can foster interspecies communication and enable
bacteria to modify behaviors such as virulence, luminescence,
and biofilm formation across different species (Armbruster
et al., 2010; Cuadra-Saenz et al., 2012; Pereira et al., 2008; Xav-
ier and Bassler, 2005a). This feature makes AI-2 an excellent
candidate for mediating cell-cell interactions in the mammalian
gut, where hundreds of bacterial species co-exist and interact.
Multiple gut-associated bacteria that encode the AI-2 synthase,
LuxS, or produce AI-2 have already been identified (Antunes
et al., 2005; Hsiao et al., 2014; Luka´s et al., 2008; Schauder
et al., 2001). Furthermore, the human commensal bacterium
Ruminococcus obeum was recently reported to inhibit coloniza-
tion of the mouse gut by V. cholerae, partially through AI-2
signaling, highlighting how AI-2 produced by commensal bacte-
ria can affect invading pathogens (Hsiao et al., 2014).We hypoth-
esized that signaling through AI-2 might also occur between
commensal members of the microbiota and asked whether
AI-2 can shape the species composition of this community under
conditions of dysbiosis.
To investigate this hypothesis, we made use of the natural
signal production and depletion capabilities of the enteric bacte-
rium, Escherichia coli. This organism secretes large amounts of
AI-2 into the environment; it also harbors a highly efficient mech-
anism for signal uptake and degradation, known as the Lsr trans-
port system (Pereira et al., 2012; Xavier and Bassler, 2005b). By
internalizing and processing AI-2 produced by itself as well as
from other species, Lsr system-expressing bacteria can disrupt
the ability of neighboring species to correctly determine popula-
tion density and regulate AI-2-dependent behavior appropri-
ately, as shown in vitro in mixed cultures of E. coli and Vibrio
spp. (Xavier and Bassler, 2005a). As a result, this system has
been explored as a potential means for AI-2 interspecies quorum
quenching (Roy et al., 2010). Given that E. coli can also stably
colonize the mouse gut following streptomycin treatment (Con-
way et al., 2004), we used this bacterium as a tool to manipulate
AI-2 signaling in vivo and demonstrated the accumulation and
depletion of AI-2 in the intestinal tract of gnotobiotic mice. Strep-
tomycin induces gut dysbiosis and has been used extensively to
study Salmonella pathogenesis and E. coli physiology following
the disruption of colonization resistance (Barthel et al., 2003;
Spees et al., 2013). We characterized the changes induced by
streptomycin upon the composition of the microbiota and then
determined the effect of E. coli-mediated AI-2 manipulation
upon this antibiotic-treated community.
RESULTS
Engineered E. coli Mutants Manipulate AI-2 Availability
in the Mouse Gut
To manipulate AI-2 levels in the mouse gut, we constructed a
combination of E. coli mutants affected in the Lsr system that1862 Cell Reports 10, 1861–1871, March 24, 2015 ª2015 The Authoraccumulate different levels of AI-2 in vitro. To obtain high levels
of AI-2, we constructed a mutant in lsrK, which encodes the
signal kinase required for phosphorylation and intracellular
retention of the signal. In the absence of LsrK, E. coli cannot
sequester nor degrade AI-2 intracellularly, so the molecule
accumulates extracellularly. To deplete environmental AI-2, we
deleted lsrR, as it encodes a repressor of the Lsr transport
system. In this mutant, the Lsr transporter is constitutively ex-
pressed at high levels and this strain is highly efficient at internal-
izing and scavenging environmental AI-2. The signal synthase,
LuxS, was also deleted to produce mutants that do not produce
AI-2 and thus do not contribute to the extracellular pool of AI-2.
Thesemutationswere introduced into a YFP-expressing strain of
E. coli to ease identification of bacteria recovered from mice.
In vitro validation of these strains confirmed that the DlsrK
mutant strain accumulated and maintained high extracellular
AI-2 levels (Figure S1A). Bacteria affected in lsrR rapidly internal-
ized the signal, whereas no AI-2 could be detected in cultures
containing mutants in the AI-2 synthase gene, luxS. We also
confirmed that the DlsrRDluxSmutant strain internalized exoge-
nously supplied AI-2 and could be used as a tool to deplete envi-
ronmental signal (Figure S1B). No uptake occurred in cultures of
DlsrKDluxSmutant bacteria provided with the signal, confirming
that this strain does not deplete AI-2 in vitro (Figure S1B).
Germ-free C57BL/6J mice were then mono-colonized with
either wild-type (WT), DlsrK, or DlsrRDluxS mutant E. coli to
determine the effect of each strain on AI-2 accumulation, without
interference from other bacteria resident in the intestinal tract
that might also produce or import AI-2. An additional group of
germ-free mice was gavaged with PBS to provide a negative
control. All E. coli strains colonized the mice to the same level,
with approximately 109 colony-forming units (CFU)/g feces re-
covered 5 days after inoculation (Figure S1C). To determine
the levels of AI-2 in the intestinal tract at this time point, extracts
of the cecal contents were analyzed using a Vibrio harveyi
biosensor that produces light in response to AI-2. Extracts
from WT- and DlsrK-gavaged mice induced almost 25-fold
more light production than cecal extracts from the control
PBS-gavaged germ-free mice (Figure 1), demonstrating that
these strains produce AI-2 in vivo, which accumulates in the
gastrointestinal tract. The similar levels of AI-2 observed in these
extracts, from WT- and DlsrK-colonized mice, suggest that Lsr
transporter expression in the WT may be repressed in the
cecum. This could be the result of inhibition by metabolites pre-
sent in the gut, as glucose and other compounds such as glyc-
erol are known to negatively regulate expression of this system
(Pereira et al., 2012; Xavier and Bassler, 2005b). No signal was
detected in extracts from mice colonized with DlsrRDluxS, a
non-AI-2-producing mutant E. coli (Figure 1).
To determine whether DlsrRDluxS mutant E. coli could scav-
enge AI-2 present in the gut, germ-free mice were gavaged
with a 1:1 mix of DlsrK E. coli (to provide AI-2) in combination
with either the DlsrRDluxS mutant (which removes but does
not produce signal in vitro) or the control strain, DlsrKDluxS
(which neither produces nor internalizes signal). As predicted
from our in vitro results, no AI-2 was detected in cecal contents
from mice colonized with the mixture of DlsrK and DlsrRDluxS
mutants, whereas those from mice co-colonized with the DlsrKs
Figure 1. E. coli Accumulate and Deplete AI-2 in the Gut of Mono-
colonized Mice
AI-2 activity in cecal extracts harvested from germ-free mice 5 days after
gavage with PBS, WT, DlsrK or DlsrRDluxS; or a 1:1 mix of DlsrK and
DlsrRDluxS; or DlsrK and DlsrKDluxS E. coli, as measured by Vibrio harveyi
bioluminescence. Data shown are the mean, and the error bars correspond to
SD; n = 3. See also Figure S1.and DlsrKDluxSmixture clearly contained signal (Figure 1). Total
bacterial loads were similar in both groups of mice (Figure S1C),
and the ratio between mutant bacterial strains remained close to
one (Figure S1D). These data showed that there were no differ-
ences in the numbers of AI-2-producing DlsrK bacteria between
the two groups, which could have otherwise explained the
different levels of AI-2 detected. This demonstrates that the
DlsrRDluxS strain can efficiently internalize AI-2 in the gut and
thus that deletion of lsrR relieved repression of the Lsr
transporter. In summary, these results show that DlsrK and
DlsrRDluxS mutant E. coli can be used to manipulate AI-2
signaling, either accumulating or scavenging AI-2 in the mouse
gut, respectively, and validate the use of the DlsrKDluxS strain
as a control that does not influence signal levels.
Streptomycin Induces Major Changes in the Fecal
Microbiota
Streptomycin disrupts the microbiota, inducing a breakdown in
colonization resistance, which enables E. coli to colonize the
gut to high levels (Conway et al., 2004). We reasoned that this
would provide a good system to determine the effect of AI-2
manipulation mediated by E. coli on the composition of the mi-
crobiota. In the absence of a detailed metagenomic description
of the dysbiosis caused by prolonged exposure to streptomycin,
we characterized the effect of this antibiotic upon the gut bacte-
rial community during 28 days of treatment without manipulation
of AI-2 levels. Antibiotic treatment decreased bacterial load:
4 days after the initial administration of antibiotic, density had
dropped almost 20-fold from 1.61 3 1010 bacterial 16S rRNA
gene copies/g feces in untreated mice to 8.36 3 108 copies/gCellfeces (Figure 2A). Despite continued exposure to streptomycin,
the total bacterial load gradually increased after day 4 and
stabilized 5- to 10-fold lower than that observed in untreated
mice.
Streptomycin also induced major changes to the composition
of the microbiota, as shown by high-throughput sequencing of
the 16S rRNA genes amplified from DNA recovered from feces
and analysis of the most abundant taxa prior to and during
treatment (Figure 2B). Before treatment, the microbiota was
composed of many different phylotypes, the majority of which
belonged to the two phyla that commonly predominate among
the gut bacterial community, the Firmicutes and the Bacteroi-
detes. These constituted 43% and 48%, respectively, of the
bacteria detected (Figure 2C), with other phyla such as the
Proteobacteria, Actinobacteria, and Deferribacteres present at
low abundances, as previously observed in the mammalian gut
(Stecher et al., 2007; Turnbaugh et al., 2010). Many of these
taxa could no longer be detected 28 days into streptomycin
treatment (Figures 2B and 2C), indicating an antibiotic-induced
decrease in diversity of the gut bacterial community. Concur-
rently, only a few populations expanded. This trend of multiple
losses and few increases was also visible at the lower taxonomic
level when the relative frequencies of the 100 most-abundant
operational taxonomic units (OTUs) (defined with 97% sequence
similarity) were analyzed over time (Figure S2A). Many OTUs had
already decreased in abundance below the level of detection
only 2 days after the onset of treatment and did not subsequently
recover (white boxes, Figure S2A). By day 28, just three OTUs,
belonging to the Bacteroidetes phylum (OTU1, 2, and 4), consti-
tuted more than 60% of the bacteria detected in each mouse
analyzed (Figure S3). This apparent decrease in community
diversity was confirmed upon quantification of both the Chao
richness index and the Shannon diversity index. These indexes
both decreased by day 2 of treatment and remained low in strep-
tomycin-treated microbiota when compared to those calculated
from the untreated samples (Figures S2B andS2C). Thus, neither
richness nor diversity of the microbiota recovered in the pres-
ence of antibiotic.
At the higher phylogenetic level, these changes drove a major
shift in the balance between the Bacteroidetes and Firmicutes.
From day 2, the Bacteroidetes had reached a relative abundance
of approximately 90%and remained at this level during the treat-
ment (Figure 2D). In contrast, the Firmicutes decreased hugely
and only represented 0.7% of the bacterial community by the
end of the experiment (Figures 2C and 2D). Despite fluctuations
in the relative abundance of some phylotypes of the Proteobac-
teria (Figure S3, yellow), no significant difference was seen in the
prevalence of this phylum.
Though streptomycin induced consistent changes in the ratio
of Firmicutes to Bacteroidetes in all mice, its effect varied greatly
at the individual OTU level during the early stages of antibiotic
treatment. This is shown by the distinct changes in presence
and abundance of specific OTUs in the different animals (Figures
S2A and S3), which appeared to stabilize by day 28. The Jaccard
distance, which provides a measure of dissimilarity taking into
account the presence and absence of OTUs in the microbiota
of each mouse, confirmed the apparent increase in inter-individ-
ual variation between the communities on days 4, 7, and 12 ofReports 10, 1861–1871, March 24, 2015 ª2015 The Authors 1863
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Figure 2. Streptomycin Changes Intestinal Microbiota Load and Composition
Streptomycin was given to four non-littermate mice in drinking water for 28 days. Animals were housed in separate cages, and fecal samples were collected for
microbiota analysis prior to and 2, 4, 7, 12, and 28 days into streptomycin treatment.
(A) Total microbiota load measured from DNA by qPCR of the 16S rRNA gene copy number/g feces.
(B) Intestinal microbiota composition at the time points indicated. Each stacked bar represents the mean of the most abundant bacterial taxa in all the mice. The
colored segments represent the relative fraction of each bacterial taxon.
(C) Relative abundance of the major phyla found in the gut microbiota before and after 28 days of treatment. Data shown are the mean ± the SD.
(D) Relative abundance of the Bacteroidetes (red circles) and Firmicutes (blue circles).
(E) Phylogenetic dissimilarities betweenmicrobial communities on each day determined by themean unweighted Unifrac distance of the bacterial communities of
each mouse versus all other mice.
Data shown in (A), (D), and (E) are the median, and the error bars show the interquartile range. Data were analyzed with the paired Student’s t test (*p < 0.05). n = 4
except for day 2, where n = 3. See also Figures S2 and S3.antibiotic treatment, followed by a decrease on day 28 (Fig-
ure S2D). This variability also affected the phylogenetic distance
of the communities, as the unweighted UniFrac distance simi-
larly increased after exposure to streptomycin and then
lowered in the bacterial communities present on day 28 (Fig-1864 Cell Reports 10, 1861–1871, March 24, 2015 ª2015 The Authorure 2E). Distance measurements were in fact smaller for the
microbiota after 28 days of streptomycin treatment than when
untreated, showing a reduction in mouse-mouse variability
upon prolonged antibiotic treatment (Figures 2E and S2D). These
results demonstrate a highly variable effect of streptomycin upons
AB
Figure 3. E. coli Colonization Levels and Total Microbiota Load in
Streptomycin-Treated Mice
Individually housedmice were given streptomycin in drinking water and 2 days
into treatment were colonized with the different E. coli mutants as specified.
Fecal samples were collected at time points indicated.
(A) Loads of E. colimutant strains as CFU/g feces from mice gavaged with the
different E. coli mutants.
(B) Total microbiota (gray bars) and E. colimutants (white bars) loads from day
28, determined by qPCR of 16S rRNA or yfp gene copy number/g feces from
DNA extracted from fecal samples frommice from each of the different groups.
Data shown are the median, and the error bars show the interquartile range;
n = 9 per group.the gut-associated bacteria within different mice during the early
phases of antibiotic treatment that became more consistent
across individuals by day 28. As the overall effect of the antibiotic
was reproducible at this stage, this time point was selected for
subsequent analysis of the influence of AI-2 on the bacterial
community that emerges as a consequence of streptomycin-
induced dysbiosis.
AI-2 Produced by E. coli Increases the Ratio of
Firmicutes to Bacteroidetes during
Streptomycin-Induced Dysbiosis
To determine whether AI-2 influences the species composition
of the gut microbial community established during long-termCellstreptomycin treatment, individually housed mice were gavaged
2 days after the start of antibiotic treatment with either DlsrK,
DlsrRDluxS, or DlsrKDluxS YFP-expressing streptomycin-resis-
tant E. coli. All three strains colonized the mice to similar levels,
with approximately 108 CFU/g feces recovered throughout the
experiment (Figure 3A). qPCR confirmed that E. coli colonization
levels, and also the total bacterial load of the microbiota, were
the same in all the three groups of mice 28 days after the start
of antibiotic treatment (which corresponded to 26 days of
E. coli colonization; Figure 3B).
Metagenomic analysis of the microbiota in fecal samples from
day 28 of treatment using PCoA of the Jaccard index (Figure 4A)
revealed that the structure of the microbiota in mice colonized
with DlsrKmutant bacteria was significantly different from those
in mice colonized with either of the other two groups (AMOVA
test; p = 0.007,DlsrK versusDlsrRDluxS; p = 0.006, DlsrK versus
DlsrKDluxS). No significant difference was observed between
the communities of DlsrRDluxS- and DlsrKDluxS-colonized
mice (p = 0.572). PCoA of the unweighted Unifrac showed the
same trend, as the structure of the microbiota was also signifi-
cantly different in terms of phylogeny between mice colonized
by DlsrK and DlsrRDluxS or DlsrKDluxS mutant E. coli (AMOVA;
p = 0.021 and p = 0.019, respectively; Figure 4B). This was due to
the changes in relative abundance of multiple OTUs in DlsrK
mutant-colonized mice compared to those in the mice contain-
ing either of the other two E. coli strains. The abundances of
six OTUs were significantly different when compared between
mice colonized by DlsrK and those containing DlsrKDluxS or
the DlsrRDluxS bacteria (shown in Figures 4C–4H); other OTUs
showed a similar trend for both comparisons but significant dif-
ferences for only one of these cases (Figure S4). Some of the
observed changes were considerable: OTU2, a member of the
Bacteroidales order present at very high abundance on day 28,
more than halved in frequency from 20.5% to 7.3% in
the DlsrKDluxS- and DlsrK-colonized mice, respectively (Fig-
ure S4A). No significant differences were observed when the
abundances of the OTUs detected in mice colonized with either
DlsrKDluxS or DlsrRDluxS were compared.
Most OTUs that changed in abundance were less prevalent
in the presence of DlsrK mutant E. coli than when in the pres-
ence of either of the other two mutants (red colors, Figure 4I).
These OTUs were all members of the Bacteroidetes phylum
and included two from the Bacteroidales order and a member
of the Porphyromonadaceae family. In contrast, one OTU clas-
sified as a Lachnospiraceae (a family within the Clostridiales
order of Firmicutes) was increased in the presence of DlsrK
mutant bacteria compared to both of the other groups (Fig-
ure 4C). Another member of the Lachnospiraceae family and
an OTU correlating to the Parasutterella genus (classified within
Burkholderiales order of Proteobacteria) were also found
at significantly higher frequencies in the fecal microbiota of
DlsrK-colonized mice compared to those harboring DlsrKDluxS
mutant bacteria (Figures S4B and S4D). These changes in
abundance of multiple OTUs when in the presence of AI-2-pro-
ducing (DlsrK) bacteria combined to give a significant effect
at the phylum level (Figure 5). The Bacteroidetes, which again
dominated the microbiota, were significantly lower in abun-
dance in the DlsrK mutant-containing mice than in thoseReports 10, 1861–1871, March 24, 2015 ª2015 The Authors 1865
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Figure 4. Microbiota Composition of Streptomycin-Treated Mice Differs in the Presence of DlsrK Mutant E. coli
Intestinal microbiota composition was analyzed in samples collected from the same mice as in Figure 3 after 28 days of antibiotic exposure (corresponding to
26 days of E. coli colonization; n = 9 per group).
(A and B) Analysis of the overall microbiota of the different E. coli groups by PCoA plots of Jaccard and unweighted Unifrac distances, respectively. The first two
coordinates are shown. Each group is labeled with a different color, as indicated. Ellipses centered on the categorical averages of themetric distances with a 95%
confidence interval for the first two coordinates of each group were drawn on the associated PCoA.
(C–H) Relative abundance of individual OTUs that exhibited a significant difference between the group colonized with DlsrK and both the other two groups are
shown. Data shown are the median, and error bars show the interquartile range. Data were analyzed with the Wilcoxon test using the Benjamini-Hochberg
correction (*q < 0.1; **q < 0.05; ns, not significant).
(I) Heatmap showing the fold change in relative abundance of OTUs in mice colonized with DlsrKmutant bacteria divided by the mean of the same OTU in mice
colonized with either the DlsrRDluxS or the control group, DlsrKDluxS, E. coli. All the OTUs that exhibited a significant difference between the different groups are
shown.
See also Figure S4.colonized with either DlsrRDluxS or DlsrKDluxS bacteria (Fig-
ure 5A). In contrast, the Firmicutes were positively affected
by the presence of AI-2-producing DlsrK mutant bacteria, un-1866 Cell Reports 10, 1861–1871, March 24, 2015 ª2015 The Authordergoing 3- to 6-fold increase to 0.8% from a relative abun-
dance of 0.24% and 0.13% in mice colonized with DlsrKDluxS
or DlsrRDluxS mutant bacteria, respectively (Figure 5B). Thiss
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Figure 5. Colonization with DlsrK Mutant Bacteria Changes the
Relative Abundance of the Major Phyla
(A and B) Relative abundances of the (A) Bacteroidetes and (B) Firmicutes
phyla in streptomycin-treated mice colonized with either DlsrKDluxS,DlsrK, or
DlsrRDluxS mutant E. coli (samples were collected 28 days into streptomycin
treatment).
(C) The corresponding ratio of the relative abundances of Firmicutes to
Bacteroidetes from the data described above.
Data shown are the median, and the error bars show the interquartile range
of n = 9 per group. Data were analyzed with the Wilcoxon test using the
Benjamini-Hochberg correction (**q < 0.05; ***q < 0.01; ns, not significant).resulted in an increase in the ratio of Firmicutes to Bacteroi-
detes. Though this increase was significant (Figure 5C), the ra-
tio in these DlsrK mutant-colonized mice remained much lower
than that observed in the microbiota of untreated animals
(0.897). Interestingly, the Bacteroidetes and Firmicutes are pre-
dicted to have very different AI-2 production capabilities: 17%
and 83% of currently sequenced genomes (KEGG database)Cellcorresponding to these two phyla, respectively, encode homo-
logs to the AI-2 synthase (Figure 6).
In conclusion, the presence of DlsrK mutant bacteria, which
accumulate high levels of AI-2, changed the abundance of the
Bacteroidetes and Firmicutes. The latter group were favored
despite the continued presence of streptomycin, providing
evidence that the bacterial communication molecule, AI-2, can
modulate the composition of gut microbiota.
DISCUSSION
There is increasing evidence that microbe-microbe interactions
influence the composition of the gut microbiota and affect the
balance of this community. Our data support this notion by
revealing that the administration of AI-2-producing bacteria
into antibiotic-treated gut microbiota affected the abundance
of multiple phylotypes and changed the overall structure of the
emerging microbial community. Streptomycin caused a drop in
bacterial load consistent with those seen in previous studies
that analyzed single-dose or short-term treatments (Garner
et al., 2009; Sekirov et al., 2008; Stecher et al., 2007). We also
characterized the effect of streptomycin treatment using meta-
genomics and observed major changes to the bacterial commu-
nity. Richness and diversity decreased due to a decrease
in abundance, often to below the level of detection, of many
OTUs: 80% of those present in untreated mice were undetect-
able by day 28 of streptomycin treatment. Such losses are likely
to free niches for colonization and expansion by other members
of this community that are better adapted to growth in the
presence of antibiotics that can take advantage of the lower
abundance of competitors.
Streptomycin is generally thought to create an environment
favorable for growth of the Proteobacteria (Stecher et al.,
2007). Though dose-dependent increases in prevalence of a
bacterial group that included the Bacteroidetes were also previ-
ously reported (Sekirov et al., 2008), we had expected to see the
expansion of the resident members of Proteobacteria. However,
we observed only transient expansions of this phylum whereas
the Bacteroidetes dominated, perhaps as a result of our longer
antibiotic treatment (Stecher et al., 2007). Streptomycin resis-
tance is easily acquired by spontaneous mutations: it is possible
that the prevalence of Bacteroidetes was due to amajor compet-
itive advantage conferred upon bacteria that were resistant
to streptomycin. Whether pre-existing or acquired during the
course of treatment, this resistance could therefore be a major
cause for the expansion of the OTUs most abundant at the end
of treatment. These OTUs, all members of the Bacteroidetes
phylum, were consistently present across all mice tested
(OTUs 1, 2, and 4; Figure S3). As acquisition of resistance by in-
dependent spontaneous mutation events in the same OTUs in
each of the mice during this treatment seems unlikely, this sug-
gests that streptomycin-resistant members were already pre-
sent in untreated mice and were subsequently selected for on
exposure to antibiotic. Additionally, our data suggest that either
the prevalence of streptomycin resistance or the propensity to
gain it is higher among the Bacteroidetes than the Firmicutes.
Though selection of resistant strains is likely to be a consider-
able force in shaping the community that emerges duringReports 10, 1861–1871, March 24, 2015 ª2015 The Authors 1867
Figure 6. Higher Prevalence of LuxS Orthologs in the Complete Genomes of Bacteria Belonging to the Firmicutes
Percentage of full genome sequences corresponding to members of the Bacteroidetes and Firmicutes containing protein orthologs of LuxS.antibiotic treatment, marked differences in relative abundance of
the different phylotypes present at the end of our treatment were
observed. This finding suggests that individual species have
different abilities to exploit the space freed upon antibiotic treat-
ment and that other antagonistic or synergistic interactions such
as competition between species with similar metabolic demands
and functions must also influence the growth of these microbes
(Stecher et al., 2010). Given the high bacterial densities found
within the multispecies gut environment, we asked whether
the interspecies quorum sensing signal AI-2 could influence
the presence and prevalence of species interacting within the
microbiota during the emergence of the streptomycin-treated
community.
Using E. coli strains engineered to either accumulate or
deplete AI-2 in vivo, we demonstrated that manipulation of
signal levels had no effect upon the numbers of E. coli itself (vali-
dating the use of this bacterium as a tool) nor upon the overall
density of the microbiota upon colonization of streptomycin-
treated mice. However, analysis of the species composition re-
vealed differences in the microbiota of mice colonized with the
DlsrKmutant E. coli, compared with those of the mice colonized
with the other two mutants. As this strain accumulates AI-2
extracellularly, our data suggest that increased AI-2 availability
leads to changes in the gut-associated bacteria that, at the
phylum level, increase the ratio of Firmicutes to Bacteroidetes.
This opposes the effect of streptomycin, which massively favors
the Bacteroidetes. Such changes in the abundance of the major
phyla have the potential to further influence AI-2 levels among
the microbiota: signal production capabilities vary greatly be-
tween the major phyla, with a greater proportion of Firmicutes
than Bacteroidetes encoding LuxS orthologs. By clearing
most Firmicutes, streptomycin treatment is likely to create an
environment containing relatively little AI-2, due to a paucity of
AI-2 producers among the resulting gut community. With this
in mind, it is perhaps unsurprising that the E. coli mutant strain
that scavenges AI-2 had no detectable effect upon the strepto-
mycin-treated microbiota. However, increased AI-2 availability,
in favoring the Firmicutes, promotes the group of bacteria with a
higher frequency of AI-2 producers. This positive feedback
might be necessary to provide a context to achieve quorum
and to potentiate further AI-2-dependent responses among
the microbiota.
Members of both the Firmicutes and Bacteroidetes fulfill
many functions important to host physiology, including the1868 Cell Reports 10, 1861–1871, March 24, 2015 ª2015 The Authorfermentation of diverse dietary polysaccharides too complex
to be digested by the host. This process produces short-chain
fatty acids (SCFAs) such as propionate, butyrate, and acetate
(Louis et al., 2014). These molecules, particularly butyrate, pro-
vide approximately 10% of the host’s calorie intake (McNeil,
1984) and also influence host gene expression, proinflammatory
cytokine secretion, and Treg induction (Arpaia et al., 2013;
Chang et al., 2014; Furusawa et al., 2013; Smith et al., 2013).
As a result, signaling through butyrate and other SCFAs modu-
lates inflammation within the intestinal tract (Maslowski et al.,
2009). Individual species of the Bacteroidetes and Firmicutes
are thought to make distinct contributions to the pools of
each SCFA: Firmicutes are proposed to include the major buty-
rate producers whereas increased prevalence of Bacteroidetes
has been correlated with increased proportions of propionate in
the total SCFA pool (Salonen et al., 2014). Thus, changes in
abundance of these bacteria (such as those observed here
in response to streptomycin or AI-2 availability) could alter the
concentration of these metabolites within the gut, with conse-
quent downstream effects upon host physiology, and poten-
tially explain the altered concentrations of SCFAs and increase
in inflammatory tone previously observed in the ceca of strepto-
mycin-treated mice (Garner et al., 2009; Spees et al., 2013).
Moreover, the increase in abundance of Firmicutes observed
in the presence of the AI-2-producing E. coli mutant offers the
exciting possibility that AI-2 signaling might have ameliorated
the effect of streptomycin on the microbiota-derived functions:
it favored the group of bacteria most detrimentally affected
by antibiotic treatment and may have influenced their functions
via signaling responses. Heightening the impact of signal
manipulation among the microbiota in this way can be used to
aid the identification of AI-2-regulated functions in this impor-
tant bacterial community and explore the possibility of using
AI-2 signaling to restore the protective functions of the gut mi-
crobiota or influence microbiota-induced host responses. The
results presented here will facilitate the identification of candi-
date bacteria that are more likely to be sensitive to this signal
molecule (those that favor signal producers, for example),
knowledge which can be used to design models that further
potentiate AI-2-dependent effects. This work highlights the po-
tential gain from understanding and manipulating the bacterial
chemical repertoire operating within the bacterial community
inhabiting the gut, towards the aim of tailoring the composition
of the microbiota to our benefit.s
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture Conditions
All E. coli strains and primers used in this study are listed in supplemental
tables. These are all E. coli K-12 MG1655 derivatives with a streptomycin-
resistant mutation in rpsL-1(K43N) that express CFP or YFP constitutively.
For details of culture conditions, genetic manipulation, and strain construction,
see Supplemental Experimental Procedures.
Animal Studies
All experiments involving mice were approved by the Institutional Ethics
Committee at the Instituto Gulbenkian de Cie^ncia and the Portuguese National
Entity (Direc¸a˜o Geral de Alimentac¸a˜o e Veterina´ria; ref. no. 008957, approval
date 19/03/2013) following the Portuguese legislation (PORT 1005/92), which
complies with the European Directive 86/609/EEC of the European Council.
To demonstrate AI-2 production in the gut, germ-free mice were gavaged
with sterile PBS or 105 CFUs of wild-type, DlsrK, or DlsrRDluxS E. coli strains.
To demonstrate removal of AI-2 from the gut by the E. coli DlsrRDluxSmutant
strain, germ-free mice were gavaged with a 1:1 mix of 105 CFUs of DlsrK and
DlsrKDluxS or DlsrK and DlsrRDluxS mutant bacteria labeled with either CFP
or YFP. Fecal samples were collected 5 days after colonization and plated
to determine bacterial load; cecal contents were harvested for analysis of
AI-2 levels.
6- to 8-week-old male C57BL/6J mice conventionally raised under specific
pathogen-free (SPF) conditions were used to analyze the effects of strepto-
mycin and colonization by E. colimutant strains upon the intestinal microbiota.
To determine the effects of streptomycin treatment on the gut microbiota
composition, four non-littermatemicewere housed individually andmaintained
under 5 g/l streptomycin ad libitum in the drinking water (Conway et al. 2004).
Fresh fecal samples were collected prior to antibiotic administration (day 0)
and 2, 4, 7, 12, and 28 days during treatment for subsequent DNA extraction.
To assess the effects of different E. colimutants upon the gastrointestinal flora,
five groups of mice (n = 6) were treated andmaintained under streptomycin, as
described above.Onday 2of treatment, twomiceper groupweregavagedwith
100 ml PBS containing 108 colony-forming units (CFU) of either ARO071 (DlsrK),
ARO093 (DlsrKDluxS), or ARO081 (DlsrRDluxS) and individually caged (so that
n = 10 per treatment). Fecal samples were collected, part was homogenized in
1ml sterile PBS and plated to determine colonization levels (CFU/g feces), and
the remainder of each sample was used for subsequent DNA extraction.
Detection of AI-2 Activity
AI-2 activity was measured as previously described (Taga and Xavier, 2011)
using the V. harveyi AI-2 reporter strain TL26 (DluxN DluxS DcqsS; Long
et al., 2009). To determine AI-2 activity in mouse cecal extracts, the cecal con-
tents were homogenized at a 10% weight/volume concentration in 0.1 M
MOPS (pH 7). Samples were centrifuged and filtered, and then an equal vol-
ume of methanol was added to precipitate further debris. Supernatants were
vacuum-dried, resuspended at 50% weight/volume in sterile water, and
analyzed by bioassay as above. Enumeration of V. harveyiCFUs demonstrated
no significant differences in growth of the reporter strain across the samples.
Sample Collection and DNA Extraction
DNA was extracted from fecal samples using the QIAamp DNA Stool Mini Kit
(QIAGEN) following the manufacturer’s instructions plus an additional mem-
brane disruption step using 0.1-mm glass beads and high-speed shaking.
Samples were stored at20C. Total DNA obtained was quantified with Qubit
dsDNA BR Assay Kit (Invitrogen); samples with more than 10 ng/ml were
sequenced and further analyzed (n = 9 per treatment).
Quantification of Bacterial Load by qPCR
Quantitative PCR (qPCR) was performed onDNA extracted from fecal samples
using 16S rRNA universal primers and YFP (CFP)-specific primers to deter-
mine total bacterial and YFP-expressing E. coli loads/g feces, respectively.
16S rRNA Gene Amplification, Pyrosequencing, and Analysis
For each sample, the V1–V3 region of the 16S rRNA gene was amplified by
PCR and sequenced using a 454 GS FLX Titanium platform following RocheCellrecommendations. Sequences were processed using mothur (Schloss et al.,
2009) as previously described (Ubeda et al., 2013), with some modifications.
See Supplemental Experimental Procedures for further details of all methods
and statistical analyses.
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